Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease

Published:2018-08-09 Issue:9 Volume:93 Page:E246-E248
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Zimran Ari¹^ORCID,Revel-Vilk Shoshana¹^ORCID,Becker-Cohen Michal¹,Chicco Gaya¹,Arbel Naama²,Rolfs Arndt³⁴,Szer Jeff¹⁵^ORCID

Affiliation:

1. Gaucher Unit, Shaare Zedek Medical Center; affiliated with Hadassah-Hebrew University Medical School; Jerusalem Israel

2. Medison Pharma; Petach Tikva Israel

3. Centogene AG; Institute for Rare Diseases; Rostock Germany

4. University of Rostock; Albrecht Kossel Institute for Neuroregeneration; Rostock Germany

5. Royal Melbourne Hospital and Department of Medicine University of Melbourne; Melbourne Australia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25205/fullpdf

Reference6 articles.

1. How we manage Gaucher disease in the era of choices;Revel-Vilk;Br J Haematol.,2018

2. Intravenous enzyme replacement therapy: better in home or hospital?;Milligan;Br J Nurs.,2006

3. Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: long-term data from phase III clinical trials;Hughes;Am J Hematol.,2015

4. 13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease;Elstein;Blood Cells Mol Dis.,2015

5. Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients;Rolfs;PLoS One,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease;Internal Medicine Journal;2023-07-26

2. Rapid velaglucerase alfa infusion for Gaucher disease: 5‐year data;Internal Medicine Journal;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3